Urease Breath Test for Rapid Characterization of Pneumonia

CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 4, 2020

Study Completion Date

June 4, 2020

Conditions
Pneumonia, Bacterial
Interventions
DEVICE

13C-urea breath test

Subjects will undergo 13C-urea breath test involving collection of baseline breath samples, nebulization of 13C-urea, and collection of post-nebulization breath samples

Trial Locations (1)

48202

Henry Ford Health System, Detroit

All Listed Sponsors
collaborator

Avisa Pharma Inc.

UNKNOWN

collaborator

Malvern Consulting Group, Inc.

UNKNOWN

lead

University of New Mexico

OTHER